Can Nortriptyline Cause Constipation?
Yes, nortriptyline can definitely cause constipation—it is a well-established anticholinergic side effect of this tricyclic antidepressant that occurs commonly in clinical practice.
Evidence from FDA Drug Labeling
The FDA-approved drug label for nortriptyline explicitly lists constipation as an anticholinergic adverse reaction 1. The label warns that "because of its anticholinergic activity, nortriptyline hydrochloride should be used with great caution" and specifically identifies constipation among the gastrointestinal adverse effects 1. Additionally, the label notes that constipation can progress to paralytic ileus in severe cases 1.
Clinical Evidence and Frequency
Multiple clinical studies confirm constipation as a significant side effect:
In elderly patients on long-term maintenance therapy, constipation occurred significantly more frequently at higher therapeutic plasma levels (80-120 ng/ml) compared to lower levels (40-60 ng/ml) over a 3-year period 2
In neuropathy trials, dry mouth, dizziness, and constipation were more common with nortriptyline compared to placebo 3
In smoking cessation studies, nortriptyline produced noticeably higher severity ratings for constipation compared to placebo 4
In combination therapy with morphine, moderate-to-severe constipation occurred in 43% of patients receiving nortriptyline-morphine combination versus only 5% with nortriptyline alone 5
Mechanism of Action
Nortriptyline causes constipation through its anticholinergic properties. Recent mechanistic research demonstrates that tricyclic antidepressants like nortriptyline inhibit TRPC4 channels in colonic myocytes, which disrupts normal colonic motility and directly causes constipation 6. This provides the molecular explanation for why TCAs are consistently associated with constipation as a class effect.
Clinical Context from Guidelines
The NCCN Palliative Care Guidelines specifically identify anticholinergic drugs, including antidepressants like tricyclic agents, as known causes of constipation 7. The guidelines recommend that providers "discontinue any nonessential constipating medications" when managing constipation 7.
A 2025 systematic review confirms that tricyclic antidepressants, especially tricyclic ones, are often associated with constipation 8.
Comparative Profile
Among antidepressants, amitriptyline (another tricyclic) ranks among the highest for causing constipation, and nortriptyline shares similar anticholinergic properties 9, 10. In contrast, newer antidepressants like SSRIs and SNRIs have different gastrointestinal profiles, more commonly causing nausea and diarrhea rather than constipation 10.
Clinical Management Considerations
- Anticipate and prevent: When prescribing nortriptyline, prophylactic bowel regimens should be considered, particularly in elderly patients or those on higher doses
- Dose-dependent effect: Constipation severity increases with higher plasma levels 2
- Monitor closely: The risk of progression to paralytic ileus, though rare, necessitates monitoring for severe constipation
- Consider alternatives: If constipation becomes problematic and the medication is being used for pain management, alternative agents with different side effect profiles may be warranted
The bottom line: Constipation is a predictable, common, and well-documented anticholinergic side effect of nortriptyline that should be anticipated when prescribing this medication.